Pharmaceutical Marketing

Pharmaceutical Marketing Market by Category (Conference Marketing, PPC Advertising, Print Advertising), Distribution (Generic Drug Marketing, Institutional Supply, Online Pharmacies), Business Model - Global Forecast 2024-2030

360iResearch Analyst
SPEAK TO ANALYST? OR FACE-TO-FACE MEETING?
Want to know more about the pharmaceutical marketing market or any specific requirement? Ketan helps you find what you're looking for.
DOWNLOAD A FREE PDF
This free PDF includes market data points, ranging from trend analysis to market estimates & forecasts. See for yourself.

[195 Pages Report] The Pharmaceutical Marketing Market size was estimated at USD 41.19 billion in 2023 and expected to reach USD 46.03 billion in 2024, at a CAGR 12.26% to reach USD 92.55 billion by 2030.

Pharmaceutical Marketing Market
To learn more about this report, request a free PDF copy

The pharmaceutical market, comprising the discovery, development, production, and distribution of a wide array of medicinal products for human use, is experiencing significant growth due to various factors. These include an increase in chronic diseases worldwide, advancements in medical sciences leading to innovative drug discoveries, favorable government policies encouraging investments in R&D activities, and strategic collaborations between pharmaceutical and biotechnology firms. Notable opportunities contributing to this industry's growth involve personalized medicine based on genetic information for targeted therapies; expansion into emerging markets with rapidly growing economies; digital transformation initiatives such as telemedicine services and electronic health records; adoption of artificial intelligence (AI) and machine learning (ML) tools in drug discovery processes; and increased focus on developing new vaccines to tackle global infectious diseases. However, the industry faces certain limitations and challenges such as stringent regulatory environments potentially delaying product approvals or imposing marketing restrictions on new drugs. Additionally, high costs associated with drug discovery and development can result in pricing pressures affecting patient accessibility. Counterfeit medicines pose a significant threat to patient safety and tarnish the reputation of genuine pharmaceutical products. However, growing concerns over drug-resistant pathogens necessitate continuous innovation in antibiotic research, which further facilitates the marketing need of pharmaceutical products.

Pharmaceutical Marketing Market - Global Forecast 2024-2030
To learn more about this report, request a free PDF copy
Category: Website pages & campaigns are crucial in pharmaceutical marketing strategies for commercializing pharma product

In the dynamic pharmaceutical industry, conference marketing, PPC advertising, print advertising, social media campaigns, TV commercials, and website pages & campaigns are important techniques deployed to commercialize the product. Conference marketing facilitates interaction with healthcare professionals (HCPs) through events organized by renowned entities such as The Healthcare Information and Management Systems Society (HIMSS), American Medical Association(AMA), and European Medicines Agency(EMA). Moreover, successful pharmaceutical marketing strategies combine essential conference marketing tactics with digital approaches such as PPC advertising while maintaining traditional methods like print ads. Social media offers valuable patient interaction opportunities alongside TV commercials' widespread impact but must account for cost challenges. Effective online presence through websites rounds out these comprehensive marketing efforts. Furthermore, engaging website pages & campaigns allow direct communication with target audiences with enhanced responsiveness and user-friendliness.

Distribution: PCD pharma franchises enable rapid market expansion for over-all pharmaceutical companies

Generic drug marketing aims to promote affordable, non-branded medications with identical active ingredients as branded counterparts, focusing on accessibility and efficacy. The institutional supply segment addresses the demands of healthcare institutions in hospitals, clinics, nursing homes, and long-term care facilities requiring bulk pharmaceutical supplies following specific delivery schedules. Online pharmacies are gaining traction due to consumers' increasing preference for convenience, privacy, and competitive pricing compared to traditional pharmacies. Over-the-counter (OTC) marketing focuses on non-prescription drugs available without a physician's prescription, driven by self-care trends and increased health awareness among consumers. The Propaganda cum Distribution (PCD) pharma franchise model enables established pharmaceutical companies to expand their market presence through partnerships with local entrepreneurs holding exclusive marketing and distribution rights within specific territories. This approach offers scalability, cost-effective growth, and enhanced brand recognition. By adopting tailored strategies for each segment, manufacturers can cater to diverse needs while maximizing revenue growth potential.

Business Model: B2B marketing emphasize more technical approach to meet the high standards set by regulatory agencies while providing valuable healthcare solutions

B2B pharmaceutical marketing involves selling products and services to organizations such as healthcare providers, hospitals, and research institutions. This approach fosters innovation and long-term partnerships, with major manufacturers investing in research and development initiatives. In contrast, B2C pharmaceutical marketing targets individual consumers by promoting over-the-counter medications or prescription drugs through various channels such as television commercials or social media. This model prioritizes convenience, accessibility, and brand trust. The distinct difference between B2B and B2C pharmaceutical marketing lies in their target audiences - organizations versus individual consumers.

Regional Insights

The U.S. signifies its dominance in the global pharmaceutical market due to its large population, high per capita healthcare spending, and robust intellectual property laws that encourage innovation. While Canada's pharmaceutical sector is smaller in comparison to the US market, it is noted for its focus on biopharmaceutical research and development. In Europe, the EU has heavily invested in research initiatives such as Horizon 2020 to foster innovation by funding projects that address major health challenges. In the EMEA region, Middle Eastern markets are experiencing increased demand for branded drugs due to the rising prevalence of diabetes and cardiovascular disorders as lifestyle diseases. Governments within this region aim to boost local pharma landscapes through investments in manufacturing facilities and education programs for local talent. Africa holds untapped potential with countries in South Africa, Nigeria, and Kenya leading pharmaceutical spending while focusing on infectious diseases such as HIV/AIDS, malaria, tuberculosis, and others. Government initiatives toward health improvement in the Asia-Pacific region, particularly in China, India, Japan, Australia actively promoted innovation through incentives for new drug development. Moreover, constant monitoring of patents, research developments, investment trends, and strategic initiatives is expected to aid in identifying growth opportunities worldwide within the pharmaceutical marketing landscape.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Pharmaceutical Marketing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Pharmaceutical Marketing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments
  • JB Chemicals Gets USFDA Approval For Generic Drug Marketing

    JB Chemicals & Pharmaceuticals received approval from the USFDA to market Doxepin Hydrochloride capsules in five different strengths. This product serves as a generic alternative to Pfizer's Sinequan capsules, which are commonly prescribed for mood disorders such as anxiety and depression. JB Chemicals & Pharmaceuticals plans to manufacture the drug at its formulation production facility located in Panoli, Gujarat. In terms of sales, Doxepin Hydrochloride capsules have been estimated to generate an annual revenue of approximately USD 23.90 million in the United States. [Published On: 2023-08-24]

  • Two New Partnerships For The Pharmaceutical Industry

    Croda International Plc established two new partnerships in the pharmaceutical industry to promote a more sustainable supply chain for vaccine adjuvants. Under an exclusive license agreement with Amyris, a prominent synthetic biology company, Croda will now have access to biotechnology-derived squalene, a key component used in adjuvants. Additionally, Croda has partnered with Botanical Solutions Inc (BSI) to develop a sustainable, pharmaceutical-grade QS-21 vaccine adjuvant. These strategic collaborations will enable Croda to offer vaccine developers the most suitable adjuvant systems and expedite the commercialization of packaged squalene products to its esteemed customer base. [Published On: 2023-06-19]

  • Sun Pharma Completes Acquisition of Concert Pharmaceuticals

    Sun Pharma completed the acquisition of US-based Concert Pharmaceuticals in the context of pharmaceutical marketing. As part of this acquisition, Sun Pharma has gained ownership of deuruxolitinib, a late-stage potential best-in-class treatment for alopecia areata. The company aims to expand its presence in the Boston biotech hub and further develop its global dermatology portfolio, further striving to strengthen its position in the pharmaceutical industry. [Published On: 2023-03-06]

Key Company Profiles

The report delves into recent significant developments in the Pharmaceutical Marketing Market, highlighting leading vendors and their innovative profiles. These include Amgen Inc., AstraZeneca PLC, Biogen Inc., Boehringer Ingelheim International GmbH, Bristol Myers Squibb Company, Eli Lilly & Company, F. Hoffmann-La Roche AG, GlaxoSmithKline PLC, Merck & Co. Inc., Novartis AG, Novo Nordisk A/S, Pfizer Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited, and Teva Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Pharmaceutical Marketing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Category
    • Conference Marketing
    • PPC Advertising
    • Print Advertising
    • Social Media Campaigns
    • TV Commercials
    • Website Pages & Campaigns
  • Distribution
    • Generic Drug Marketing
    • Institutional Supply
    • Online Pharmacies
    • OTC (Over The Counter) Marketing
    • PCD Pharma Franchise
  • Business Model
    • B2B
    • B2C

  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Pharmaceutical Marketing Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Pharmaceutical Marketing Market?
  3. What are the technology trends and regulatory frameworks in the Pharmaceutical Marketing Market?
  4. What is the market share of the leading vendors in the Pharmaceutical Marketing Market?
  5. Which modes and strategic moves are suitable for entering the Pharmaceutical Marketing Market?

Table of Contents
  1. Preface
  2. Research Methodology
  3. Executive Summary
  4. Market Overview
  5. Market Insights
  6. Pharmaceutical Marketing Market, by Category
  7. Pharmaceutical Marketing Market, by Distribution
  8. Pharmaceutical Marketing Market, by Business Model
  9. Americas Pharmaceutical Marketing Market
  10. Asia-Pacific Pharmaceutical Marketing Market
  11. Europe, Middle East & Africa Pharmaceutical Marketing Market
  12. Competitive Landscape
  13. Competitive Portfolio
  14. List of Figures [Total: 22]
  15. List of Tables [Total: 294]
  16. List of Companies Mentioned [Total: 15]
The Integration of Digital Tools in Pharmaceutical Marketing: A Game-Changer
October 31, 2023
BLOG
The Integration of Digital Tools in Pharmaceutical Marketing: A Game-Changer
The world as we know it has undergone a significant change in the last few years with the rise of technology. Various sectors of the economy have leveraged digital tools to enhance business operations and improve efficiencies. The pharmaceutical industry is included in this transformation; they have integrated digital tools in pharmaceutical marketing to streamline the marketing process and achieve optimized results. This blog post aims to uncover how integrating digital tools has changed the game of pharmaceutical marketing.

Increased Efficiency in Targeting and Education:

Digital tools like social media, webinars, and online medical journals allow pharmaceutical companies to educate their customers on their products. Also, these tools offer a platform to target select customers whose interests match a particular product. This approach saves the cost and time that would have been spent on delivering promotional items to physicians and customers who are not interested in the product.

Access to Real-time Data:

Digital tools allow pharmaceutical companies to track and analyze how customers interact with their products. They can analyze engagement rates on social media, track clicks and downloads on their websites, and monitor behavior on mobile apps. This data helps them modify their marketing strategies for maximum effect and allocate resources to high-performing platforms.

Improved Customer Engagement:

With digital tools, customers can access product information at their convenience. This increased accessibility allows for interactive customer engagement, where they can ask questions and get answers. Customer feedback can be monitored and responded to through social media pages, online communities, and website chatbots.

Effective Communication with Remote Health Providers:

Digital tools play a significant role in the engagement of remote healthcare providers. Pharmaceutical companies use digital tools to reach remote healthcare providers and provide them with product information. This approach eliminates the need for field visits and provides healthcare providers the convenience and privacy they need in their daily routines.

Improved Brand Awareness:

Digital tools provide various opportunities to create brand awareness. Pharmaceutical companies can create online communities and social media groups where customers can share their experiences with a product. Providing more value to customers besides marketing their products helps boost the brand's image and reputation, increasing brand loyalty.

Digital marketing in pharmaceuticals has brought changes and advantages beyond marketing metrics. With this transformation, the industry is becoming more agile and customer-centric, targeting a select few for efficiency. Integrating digital tools provides the industry and its customers benefits such as improved education, real-time data, engagement, and brand awareness. As new digital tools emerge, we believe the pharmaceutical industry will continue leveraging these technologies to create more value, ultimately leading to enhanced healthcare outcomes.

Frequently Asked Questions
  1. How big is the Pharmaceutical Marketing Market?
    Ans. The Global Pharmaceutical Marketing Market size was estimated at USD 41.19 billion in 2023 and expected to reach USD 46.03 billion in 2024.
  2. What is the Pharmaceutical Marketing Market growth?
    Ans. The Global Pharmaceutical Marketing Market to grow USD 92.55 billion by 2030, at a CAGR of 12.26%
  3. When do I get the report?
    Ans. Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
  4. In what format does this report get delivered to me?
    Ans. We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
  5. How long has 360iResearch been around?
    Ans. We are approaching our 7th anniversary in 2024!
  6. What if I have a question about your reports?
    Ans. Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
  7. Can I share this report with my team?
    Ans. Absolutely yes, with the purchase of additional user licenses.
  8. Can I use your research in my presentation?
    Ans. Absolutely yes, so long as the 360iResearch cited correctly.